German Pharmaceuticals & Biotech Potentially Undervalued Companies

Spectrum Pharmaceuticals

Market Cap: €209.9m

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.

Regeneron Pharmaceuticals

Market Cap: €59.3b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Viatris

Market Cap: €9.0b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Royalty Pharma

Market Cap: €18.4b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Amneal Pharmaceuticals

Market Cap: €2.2b

A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.

Otsuka Holdings

Market Cap: €3.5t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Grand Pharmaceutical Group

Market Cap: €20.7b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Aspen Pharmacare Holdings

Market Cap: €66.5b

Manufactures and supplies specialty and branded pharmaceutical products worldwide.

Viatris

Market Cap: €9.0b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Teva Pharmaceutical Industries

Market Cap: €15.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Bayer

Market Cap: €19.8b

Operates as a life science company worldwide.

Indivior

Market Cap: €857.1m

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Hikma Pharmaceuticals

Market Cap: €4.0b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Merck KGaA

Market Cap: €50.1b

Operates as a science and technology company in Germany.

Merck

Market Cap: €199.2b

Operates as a healthcare company worldwide.

Collegium Pharmaceutical

Market Cap: €828.1m

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Euroapi

Market Cap: €227.2m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.

Genomma Lab Internacional. de

Market Cap: €22.7b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Bayer

Market Cap: €19.8b

Operates as a life science company worldwide.

Selvita

Market Cap: €567.2m

Operates as a contract research organization worldwide.

Exact Sciences

Market Cap: €8.3b

Provides cancer screening and diagnostic test products in the United States and internationally.

China Medical System Holdings

Market Cap: €17.5b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt

Market Cap: €1.9t

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

Merck KGaA

Market Cap: €50.1b

Operates as a science and technology company in Germany.

Avantor

Market Cap: €10.0b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Amphastar Pharmaceuticals

Market Cap: €1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Catalyst Pharmaceuticals

Market Cap: €2.7b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Kyowa Kirin

Market Cap: €1.1t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Jazz Pharmaceuticals

Market Cap: €6.1b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Merck

Market Cap: €195.1b

Operates as a healthcare company worldwide.

Towa Pharmaceutical

Market Cap: €118.7b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

hVIVO

Market Cap: €109.7m

Operates as a pharmaceutical service and contract research company in the United Kingdom.

IQVIA Holdings

Market Cap: €25.7b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Goodbody Health

Market Cap: €1.3m

Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.

Charles River Laboratories International

Market Cap: €4.9b

Charles River Laboratories International, Inc.

Sanofi

Market Cap: €109.7b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.